Trial · NCT02112916
Adverse events1,508
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,508
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Arm A (Combination Chemotherapy): T-ALL | 3 | 308 | 3 |
| other | Anemia | Blood and lymphatic system disorders | Arm B (Combination Chemotherapy, Bortezomib): T-ALL | 3 | 307 | 4 |
| other | Anemia | Blood and lymphatic system disorders | Arm A (Combination Chemotherapy): T-LLy | 1 | 108 | 1 |
| other | Anemia | Blood and lymphatic system disorders | Arm B (Combination Chemotherapy, Bortezomib): T-LLy | 1 | 101 | 1 |
| other | Blood and lymphatic system disorders - Other, specify | Blood and lymphatic system disorders | Arm A (Combination Chemotherapy): T-ALL | 2 | 308 | 2 |
| other | Blood and lymphatic system disorders - Other, specify | Blood and lymphatic system disorders | Arm B (Combination Chemotherapy, Bortezomib): T-ALL | 0 | 307 | 0 |
| other | Blood and lymphatic system disorders - Other, specify | Blood and lymphatic system disorders | Arm A (Combination Chemotherapy): T-LLy | 0 | 108 | 0 |
| other | Blood and lymphatic system disorders - Other, specify | Blood and lymphatic system disorders | Arm B (Combination Chemotherapy, Bortezomib): T-LLy | 0 | 101 | 0 |
| other | Bone marrow hypocellular | Blood and lymphatic system disorders | Arm A (Combination Chemotherapy): T-ALL | 1 | 308 | 1 |
| other | Bone marrow hypocellular | Blood and lymphatic system disorders | Arm B (Combination Chemotherapy, Bortezomib): T-ALL | 0 | 307 | 0 |
| other | Bone marrow hypocellular | Blood and lymphatic system disorders | Arm A (Combination Chemotherapy): T-LLy | 0 | 108 | 0 |
| other | Bone marrow hypocellular | Blood and lymphatic system disorders | Arm B (Combination Chemotherapy, Bortezomib): T-LLy | 0 | 101 | 0 |
| other | Disseminated intravascular coagulation | Blood and lymphatic system disorders | Arm A (Combination Chemotherapy): T-ALL | 1 | 308 | 1 |
| other | Disseminated intravascular coagulation | Blood and lymphatic system disorders | Arm B (Combination Chemotherapy, Bortezomib): T-ALL | 0 | 307 | 0 |
| other | Disseminated intravascular coagulation | Blood and lymphatic system disorders | Arm A (Combination Chemotherapy): T-LLy | 1 | 108 | 1 |
| other | Disseminated intravascular coagulation | Blood and lymphatic system disorders | Arm B (Combination Chemotherapy, Bortezomib): T-LLy | 1 | 101 | 1 |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Arm A (Combination Chemotherapy): T-ALL | 16 | 308 | 20 |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Arm B (Combination Chemotherapy, Bortezomib): T-ALL | 25 | 307 | 29 |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Arm A (Combination Chemotherapy): T-LLy | 6 | 108 | 11 |
| other | Febrile neutropenia | Blood and lymphatic system disorders | Arm B (Combination Chemotherapy, Bortezomib): T-LLy | 7 | 101 | 9 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02112916/events